Health Boards
Mon-20-04-2015, 22:31 PM
(This post was last modified: Tue-21-04-2015, 01:40 AM by Quest4Cure.
Edit Reason: Subject sensitive according to rules.
)
Clinical trials for bio drugs for psoriatic arthritis are continuing to do research to prevent bone damage from PsA...research for psoriatic arthritis are done in 3 trials then it can be approved.
Quote [The primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis. The key secondary objective is to evaluate the efficacy of brodalumab compared to placebo at week 16 and week 24. The safety objective of this study is to evaluate the safety profile of brodalumab in subjects with psoriatic arthritis.]
Phase 1&2 studies on how the drug works to prevent bone damage has been encouraging.
As long as there is breath there is life...life is a Gift!
Quote [The primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis. The key secondary objective is to evaluate the efficacy of brodalumab compared to placebo at week 16 and week 24. The safety objective of this study is to evaluate the safety profile of brodalumab in subjects with psoriatic arthritis.]
Phase 1&2 studies on how the drug works to prevent bone damage has been encouraging.
As long as there is breath there is life...life is a Gift!
